Lene Sofie Granfeldt Østgård, Mette Nørgaard, and Jan Maxwell Nørgaard, Aarhus University Hospital, Aarhus; Lone Smidstrup Friis, The University Hospital Rigshospitalet, Copenhagen; Claudia Schoellkopf, Herlev Hospital, Herlev; Marianne Tang Severinsen, Aalborg University Hospital, Aalborg; Claus Werenberg Marcher, Odense University Hospital, Odense, Denmark; and Bruno C. Medeiros, Stanford University School of Medicine, Stanford, CA.
J Clin Oncol. 2017 Nov 10;35(32):3678-3687. doi: 10.1200/JCO.2017.73.6728. Epub 2017 Sep 11.
Purpose Previous US studies have shown that socioeconomic status (SES) affects survival in acute myeloid leukemia (AML). However, no large study has investigated the association between education or income and clinical characteristics, treatment, and outcome in AML. Methods To investigate the effects of education and income in a tax-supported health care system, we conducted a population-based study using individual-level SES and clinical data on all Danish patients with AML (2000 to 2014). We compared treatment intensity, allogeneic transplantation, and response rates by education and income level using logistic regression (odds ratios). We used Cox regression (hazard ratios [HRs]) to compare survival, adjusting for age, sex, SES, and clinical prognostic markers. Results Of 2,992 patients, 1,588 (53.1%) received intensive chemotherapy. Compared with low-education patients, highly educated patients more often received allogeneic transplantation (16.3% v 8.7%). In intensively treated patients younger than 60 years of age, increased mortality was observed in those with lower and medium education (1-year survival, 66.7%; adjusted HR, 1.47; 95% CI, 1.11 to 1.93; and 1-year survival, 67.6%; adjusted HR, 1.55; CI, 1.21 to 1.98, respectively) compared with higher education (1-year survival, 76.9%). Over the study period, 5-year survival improvements were limited to high-education patients (from 39% to 58%), increasing the survival gap between groups. In older patients, low-education patients received less intensive therapy (30% v 48%; adjusted odds ratio, 0.65; CI, 0.44 to 0.98) compared with high-education patients; however, remission rates and survival were not affected in those intensively treated. Income was not associated with therapy intensity, likelihood of complete remission, or survival (high income: adjusted HR, 1.0; medium income: adjusted HR, 0.96; 95% CI, 0.82 to 1.12; low income: adjusted HR, 1.06; CI, .88 to 1.27). Conclusion In a universal health care system, education level, but not income, affects transplantation rates and survival in younger patients with AML. Importantly, recent survival improvement has exclusively benefitted highly educated patients.
目的 先前的美国研究表明,社会经济地位(SES)会影响急性髓细胞白血病(AML)的生存。然而,尚无大型研究调查教育或收入与 AML 的临床特征、治疗和结局之间的关系。
方法 为了在税收支持的医疗保健系统中研究教育和收入的影响,我们使用丹麦所有 AML 患者(2000 年至 2014 年)的个体 SES 和临床数据进行了一项基于人群的研究。我们使用逻辑回归(比值比)比较了不同教育和收入水平下的治疗强度、异体移植和缓解率。我们使用 Cox 回归(风险比 [HR])比较了调整年龄、性别、SES 和临床预后标志物后的生存情况。
结果 在 2992 名患者中,1588 名(53.1%)接受了强化化疗。与低教育程度的患者相比,高教育程度的患者更常接受异体移植(16.3% v 8.7%)。在年龄小于 60 岁的强化治疗患者中,中低教育程度患者的死亡率升高(1 年生存率,66.7%;调整 HR,1.47;95%CI,1.11 至 1.93;和 1 年生存率,67.6%;调整 HR,1.55;CI,1.21 至 1.98),而高教育程度患者为 76.9%。在研究期间,高教育程度患者的 5 年生存率提高仅限于高教育程度患者(从 39%提高到 58%),从而扩大了组间的生存差距。在老年患者中,与高教育程度患者相比,低教育程度患者接受的治疗强度较低(30%比 48%;调整后的比值比,0.65;CI,0.44 至 0.98);然而,在接受强化治疗的患者中,缓解率和生存率不受影响。收入与治疗强度、完全缓解率或生存率无关(高收入:调整 HR,1.0;中等收入:调整 HR,0.96;95%CI,0.82 至 1.12;低收入:调整 HR,1.06;CI,0.88 至 1.27)。
结论 在全民医保体系中,教育水平而非收入影响年轻 AML 患者的移植率和生存率。重要的是,最近的生存改善仅使高学历患者受益。